Literature DB >> 32571115

Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice.

Kabir Sardana1, Sinu Rose Mathachan2, Desh Deepak3, Ananta Khurana1, Surabhi Sinha1.   

Abstract

The utility of hydroxychloroquine for the prophylaxis and treatment of alarmingly rising COVID-19 infection has been widely explored in several studies. However, its cutaneous adverse effects among health care workers and COVID patients taking prophylactic doses has not been reported. We report cases of palmoplantar among health care workers who were on prophylactic doses of hydroxychloroquine and their management with cetirizine and methylprednisolone.

Entities:  

Keywords:  COVID; antihistamines; hydroxychloroquine; maculopapular rash; prophylaxis; pruritis; urticaria

Mesh：

Substances：

Year:  2020        PMID： 32571115     DOI： 10.1080/09546634.2020.1781041

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


  3 in total

Review 1.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

2.  A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.

Authors:  Niloufar Najar Nobari; Farnoosh Seirafianpour; Farzaneh Mashayekhi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-12-26       Impact factor: 3.858

3.  Generalized exanthema due to hydroxychloroquine during COVID-19 prophylaxis.

Authors:  Ömer Kutlu; Pınar Özdemir Çetinkaya; Habibullah Aktaş; Ahmet Metin
Journal:  Int J Clin Pract       Date:  2021-02       Impact factor: 3.149
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.